undamentalytics Newsletter
Sign in

Sintx Technologies, Inc. revenue

Sintx Technologies, Inc.'s revenue was $1.0m in fiscal 2025, down 64.7% on the year before. Since fiscal 2013 ($22.3m) it has grown at a compound -22.7% a year. Over the last twelve months it was $1.3m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2223191511011123311
Growth on the year before—+2.0%−14.5%−21.7%−26.3%−99.2%+625.3%−13.8%+2.0%+157.6%+68.3%+9.9%−64.7%—
Gross profit151513115000012201
Gross margin68.4%65.3%67.9%75.2%43.4%41.1%20.0%20.0%25.9%83.0%70.2%71.9%45.3%52.9%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Products $729,000 71.6% ▼ 41.5%
Grant and Contract $289,000 28.4% ▼ 82.4%

From Sintx Technologies, Inc.'s 10-K filed March 20, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Supplies: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Sintx Technologies, Inc. $1.3m -28.5% -15.9%
Nexgel, Inc. $12.1m 3.4% 61.2%
Orasure Technologies Inc $112m -18.9% -38.4%
Mimedx Group, Inc. $304m -22.8% -0.6%
Organogenesis Holdings Inc. $457m 6.5% 0.0%
UFP Technologies Inc $632m 7.3% 17.8%

Compare with peers

Head to head: NXGL vs SINTOSUR vs SINTMDXG vs SINT

More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies

Figures from Sintx Technologies, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sintx Technologies, Inc.